- Home
- TOUR vs GALT Comparison
TOUR vs GALT Comparison
Compare TOUR & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOUR
- GALT
- Stock Information
- Founded
- TOUR 2006
- GALT 2000
- Country
- TOUR China
- GALT United States
- Employees
- TOUR N/A
- GALT N/A
- Industry
- TOUR Transportation Services
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- TOUR Consumer Discretionary
- GALT Health Care
- Exchange
- TOUR Nasdaq
- GALT Nasdaq
- Market Cap
- TOUR 101.0M
- GALT 83.5M
- IPO Year
- TOUR 2014
- GALT N/A
- Fundamental
- Price
- TOUR $0.91
- GALT $1.31
- Analyst Decision
- TOUR
- GALT Hold
- Analyst Count
- TOUR 0
- GALT 1
- Target Price
- TOUR N/A
- GALT N/A
- AVG Volume (30 Days)
- TOUR 122.4K
- GALT 176.3K
- Earning Date
- TOUR 06-12-2025
- GALT 05-15-2025
- Dividend Yield
- TOUR 3.96%
- GALT N/A
- EPS Growth
- TOUR N/A
- GALT N/A
- EPS
- TOUR 0.09
- GALT N/A
- Revenue
- TOUR $70,367,853.00
- GALT N/A
- Revenue This Year
- TOUR $16.99
- GALT N/A
- Revenue Next Year
- TOUR $13.23
- GALT N/A
- P/E Ratio
- TOUR $10.54
- GALT N/A
- Revenue Growth
- TOUR 16.40
- GALT N/A
- 52 Week Low
- TOUR $0.71
- GALT $0.73
- 52 Week High
- TOUR $1.76
- GALT $3.17
- Technical
- Relative Strength Index (RSI)
- TOUR 46.11
- GALT 48.59
- Support Level
- TOUR $0.88
- GALT $1.22
- Resistance Level
- TOUR $0.94
- GALT $1.36
- Average True Range (ATR)
- TOUR 0.03
- GALT 0.10
- MACD
- TOUR -0.00
- GALT -0.00
- Stochastic Oscillator
- TOUR 25.44
- GALT 29.41
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.